We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 5,930 results
  1. The Role of Glycated Albumin as a Biomarker of Glycemic Control in Diabetes and Chronic Kidney Disease

    Albumin is the most abundant protein found in plasma and constitutes approximately 60% of all proteins in the blood. This high molecular weight...
    Shanel Raghubeer, Don M. Matshazi, ... Tandi E. Matsha in Biomarkers in Diabetes
    Reference work entry 2023
  2. Morphological brain alterations in dialysis- and non-dialysis-dependent patients with chronic kidney disease

    To 1) investigate the morphological brain-tissue changes in patients with dialysis- and non-dialysis-dependent chronic kidney disease (CKD); 2)...

    Huan Yu, Chaoyang Zhang, ... Qi Yang in Metabolic Brain Disease
    Article 16 January 2023
  3. IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

    Inflammation mediated by interleukin-6 (IL-6) is strongly associated with cardiovascular risk. Here we evaluated clazakizumab, a monoclonal antibody...

    Glenn M. Chertow, Anna Marie Chang, ... Myles Wolf in Nature Medicine
    Article Open access 25 May 2024
  4. Albumin: a comprehensive review and practical guideline for clinical use

    Purpose

    Nowadays, it is largely accepted that albumin should not be used in hypoalbuminemia or for nutritional purpose. The most discussed indication...

    Farshad Abedi, Batool Zarei, Sepideh Elyasi in European Journal of Clinical Pharmacology
    Article 12 April 2024
  5. The Role of Glycated Albumin as a Biomarker of Glycemic Control in Diabetes and Chronic Kidney Disease

    Albumin is the most abundant protein found in plasma and constitutes approximately 60% of all proteins in the blood. This high molecular weight...
    Shanel Raghubeer, Don M. Matshazi, ... Tandi E. Matsha in Biomarkers in Diabetes
    Living reference work entry 2022
  6. Determination of drug-related problems according to PAIR criteria in dialysis patients: a cross-sectional study in tertiary care hospital

    Background

    Dialysis patients are at high risk for drug-related problems (DRPs), which have significant consequences for their morbidity, mortality,...

    Aysel Pehlivanli, Sayeste Akkan Eren, ... A. Tanju Ozcelikay in BMC Pharmacology and Toxicology
    Article Open access 18 April 2024
  7. Quality by design empowered preparation of itraconazole albumin nanoparticles for prostate cancer

    The current advent explores the potential of itraconazole (ITR) in prostate cancer (PCa), by its incorporation into albumin nanoparticles (NP). ITR...

    Saurabh Shah, Paras Famta, ... Saurabh Srivastava in Drug Delivery and Translational Research
    Article 02 May 2024
  8. A Quality by Design Paradigm for Albumin-Based Nanoparticles: Formulation Optimization and Enhancement of the Antitumor Activity

    Purpose

    Albumin nanoparticles are promising carriers for therapeutic agents, owing to their biocompatibility, safety, and versatility in fabrication....

    Marwa H. S. Dawoud, Amira Abdel-Daim, ... Nabila M. Sweed in Journal of Pharmaceutical Innovation
    Article Open access 08 May 2023
  9. Exploring the synergistic behavior of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer management

    Breast cancer is challenging to treat accompanied with poor clinical outcomes. Paclitaxel (PTX) is a first-line chemotherapeutic agent, but possesses...

    Ashwin Abhang, Oly Katari, ... Sanyog Jain in Drug Delivery and Translational Research
    Article 21 August 2023
  10. The Redox State of Serum Albumin as a Potential Protein Nutrition Biomarker

    Albumin comprises the largest part of total serum proteins in humans and is exclusively synthesized in the liver, before being distributed into the...
    Yasuaki Wada in Biomarkers in Nutrition
    Reference work entry 2022
  11. Human Serum Albumin-enriched Clopidogrel Bisulfate Nanoparticle Alleviates Cerebral Ischemia–Reperfusion Injury in Rats

    Purpose

    Cerebral ischemia reperfusion (I/R) injury remains a leading cause of mobility and mortality among patients with ischemic stroke. This study...

    Yiting Luo, Yunli **a, ... Li Deng in Pharmaceutical Research
    Article 08 June 2023
  12. The Redox State of Serum Albumin as a Potential Protein Nutrition Biomarker

    Albumin comprises the largest part of total serum proteins in humans and is exclusively synthesized in the liver, before being distributed into the...
    Yasuaki Wada in Biomarkers in Nutrition
    Living reference work entry 2022
  13. Albumin therapy for hepatic encephalopathy: current evidence and controversies

    Hepatic encephalopathy (HE) is a common complication that occurs in 16–21% of end-stage cirrhosis patients. Emerging evidence suggests that systemic...

    Yu Jun Wong, **g Hong Loo in Metabolic Brain Disease
    Article 26 May 2022
  14. Ciprofloxacin HCl-loaded Albumin Nanoparticles for the Treatment of Recurrent Urinary Tract Infections: Preparation, Optimization, and Evaluation of Antibacterial Activity

    Purpose

    The present research aimed to describe a novel ciprofloxacin HCl-loaded bovine serum albumin nanoparticle formulation to improve the...

    Ozge Esim, Merve Eylul Kiymaci, Canan Hascicek in Journal of Pharmaceutical Innovation
    Article 07 February 2023
  15. Albumin-Embellished Arsenic Trioxide-Loaded Polymeric Nanoparticles Enhance Tumor Accumulation and Anticancer Efficacy via Transcytosis for Hepatocellular Carcinoma Therapy

    Arsenic trioxide (ATO) has efficient anticancer effect on hepatocellular carcinoma (HCC) in clinical trials, but its off-target distribution and side...

    Yu Huang, Zhishi Xu, ... Danfei Chen in AAPS PharmSciTech
    Article 11 April 2022
  16. Acetylcholine Analog-Modified Albumin Nanoparticles for the Enhanced and Synchronous Brain Delivery of Saponin Components of Panax Notoginseng

    Background

    Panax notoginseng saponins (PNS) are commonly used first-line drugs for treating cerebral thrombosis and stroke in China. However, the...

    Ying Yu, Li Yun Wang, ... Cheng **ao Wang in Pharmaceutical Research
    Article 21 February 2024
  17. Berberine-loaded albumin nanoparticles reverse aflatoxin B1-induced liver hyperplasia

    Hepatocellular carcinoma (HCC) can be produced from aflatoxin B1 (AFB1) administration. Although berberine (BER) acts as an anticancer agent and can...

    Sarah M. Khedr, Doaa A. Ghareeb, ... Germine M. Hamdy in BMC Pharmacology and Toxicology
    Article Open access 10 August 2023
  18. Investigations of the Interaction Mechanism Between Orphenadrine Hydrochloride and Bovine Serum Albumin by Spectroscopic and Voltammetric Techniques

    The interaction of orphenadrine hydrochloride (ORD) with the model protein, bovine serum albumin (BSA), was investigated using a variety of...

    Naveen M. Gokavi, Sharanappa T. Nandibewoor, Jayant I. Gowda in Journal of Fluorescence
    Article 28 March 2023
  19. Predicting the Stability of Lyophilized Human Serum Albumin Formulations Containing Sucrose and Trehalose Using Solid-State NMR Spectroscopy: Effect of Storage Temperature on 1H T1 Relaxation Times

    In a lyophilized protein/disaccharide system, the ability of the disaccharide to form a homogeneous mixture with the protein and to slow the protein...

    Ashley Lay-Fortenbery, Cole W. Tower, ... Eric J. Munson in The AAPS Journal
    Article Open access 03 April 2024
  20. Risk factors for sleep disorders in patients undergoing peritoneal dialysis

    Sleep disorders in patients with end-stage renal disease are common but have rarely been reported in previous studies. Therefore, we examined the...

    Gui-Ling Liu, Qiu-Nan Zhan, ... Jie Dong in Sleep and Biological Rhythms
    Article Open access 24 January 2021
Did you find what you were looking for? Share feedback.